Skip to main content
. 2021 Feb 5;11:609592. doi: 10.3389/fphar.2020.609592

Figure 1.

Figure 1

Re-purposing of FDA-approved drugs for inhibiting SARS-CoV-2 infection. (A) Schematic diagram of the screening process of the pseudovirus model. (B) The first round of screening for compounds could inhibit the infection of VSV-SARS-CoV-2-Sdel18. The abscissa and ordinate respectively indicate two repetitions of screening. Yellow circle: chloroquine. Blue circles: 44 drugs selected for the second round of screening, Green circles: remaing FDA-approved drugs.